TW200501969A - Ophthalmic compositions containing a synergistic combination of three polymers - Google Patents

Ophthalmic compositions containing a synergistic combination of three polymers

Info

Publication number
TW200501969A
TW200501969A TW093114631A TW93114631A TW200501969A TW 200501969 A TW200501969 A TW 200501969A TW 093114631 A TW093114631 A TW 093114631A TW 93114631 A TW93114631 A TW 93114631A TW 200501969 A TW200501969 A TW 200501969A
Authority
TW
Taiwan
Prior art keywords
polymers
compositions containing
ophthalmic compositions
synergistic combination
ophthalmic
Prior art date
Application number
TW093114631A
Other languages
English (en)
Other versions
TWI336257B (en
Inventor
Masood A Chowhan
Hua-Gang Chen
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of TW200501969A publication Critical patent/TW200501969A/zh
Application granted granted Critical
Publication of TWI336257B publication Critical patent/TWI336257B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093114631A 2003-06-13 2004-05-24 Ophthalmic compositions containing a synergistic combination of three polymers TWI336257B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47871303P 2003-06-13 2003-06-13

Publications (2)

Publication Number Publication Date
TW200501969A true TW200501969A (en) 2005-01-16
TWI336257B TWI336257B (en) 2011-01-21

Family

ID=33539115

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093114631A TWI336257B (en) 2003-06-13 2004-05-24 Ophthalmic compositions containing a synergistic combination of three polymers

Country Status (20)

Country Link
US (4) US7244440B2 (zh)
EP (1) EP1633324B1 (zh)
JP (2) JP4657213B2 (zh)
KR (1) KR101082345B1 (zh)
CN (1) CN100340233C (zh)
AR (1) AR047205A1 (zh)
AT (1) ATE348600T1 (zh)
AU (1) AU2004249136B2 (zh)
BR (1) BRPI0411367B1 (zh)
CA (1) CA2527417C (zh)
CY (1) CY1105877T1 (zh)
DE (1) DE602004003812T2 (zh)
DK (1) DK1633324T3 (zh)
ES (1) ES2274476T3 (zh)
MX (1) MXPA05013293A (zh)
PL (1) PL1633324T3 (zh)
PT (1) PT1633324E (zh)
TW (1) TWI336257B (zh)
WO (1) WO2004112750A2 (zh)
ZA (1) ZA200509441B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100475192C (zh) * 2003-06-13 2009-04-08 爱尔康公司 包含两种聚合物的协同组合的眼用组合物
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
EP2113246B1 (en) † 2003-08-07 2016-06-22 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
CA2567418C (en) * 2004-05-27 2012-12-04 Santen Pharmaceutical Co., Ltd. Viscous agent for ophthalmic use
JP2009521493A (ja) * 2005-12-23 2009-06-04 アルコン，インコーポレイテッド 眼への受容体チロシンキナーゼ阻害（ＲＴＫｉ）化合物の送達のための医薬製剤
FR2896152B1 (fr) * 2006-01-17 2016-01-08 Cetem Lab Nouvelles compositions cosmetiques et leur utilisation pour l'application sur les muqueuses
AR062046A1 (es) 2006-07-25 2008-08-10 Osmotica Pharmaceutical Argentina S A Soluciones oftalmicas
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
MX2009007774A (es) * 2007-02-09 2009-07-31 Alcon Inc Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.
EP2188289B1 (en) 2007-08-08 2015-10-28 Lexicon Pharmaceuticals, Inc. (7h-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazines as kinase inhibitors for the treatment of cancer and inflammation
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
KR20100133980A (ko) * 2008-03-07 2010-12-22 썬 파마 어드밴스트 리서치 컴패니 리미티드 안약 조성물
AU2009239500B2 (en) 2008-04-21 2014-01-30 Lexicon Pharmaceuticals, Inc. LIMK2 inhibitors, compositions comprising them, and methods of their use
ES2818619T3 (es) * 2008-04-26 2021-04-13 Alcon Inc Sistema de lagrima artificial polimérico
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
TWI547522B (zh) * 2009-07-07 2016-09-01 愛爾康研究有限公司 環氧乙烷環氧丁烷嵌段共聚物組成物
PL2586426T3 (pl) 2009-12-03 2016-01-29 Alcon Res Ltd Zawiesiny zawierające nanocząsteczkowe polimery karboksywinylowe
WO2011091204A1 (en) 2010-01-22 2011-07-28 Lexicon Pharmaceuticals, Inc. 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
CN102939074A (zh) * 2010-05-05 2013-02-20 爱尔康研究有限公司 稳定的眼科半乳甘露聚糖制剂
PL2787968T3 (pl) * 2011-12-07 2020-08-24 Allergan, Inc. Wydajne dostarczanie lipidów do ludzkiego filmu łzowego z użyciem wrażliwego na sól układu emulsyjnego
FR2988297B1 (fr) * 2012-03-22 2014-03-28 Thea Lab Solution ophtalmique aqueuse a base de ciclosporine a sans conservateur
TWI658828B (zh) * 2014-10-31 2019-05-11 中國醫藥大學 用於舒緩及減輕近視之醫藥組合物及其製備方法與用途
US20220054520A1 (en) * 2019-02-27 2022-02-24 Santen Pharmaceutical Co., Ltd. Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355336A (en) * 1966-08-18 1967-11-28 Du Pont Thickened water-bearing inorganic oxidizer salt explosive containing crosslinked galactomannan and polyacrylamide
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5368843A (en) * 1988-06-08 1994-11-29 Lever Brothers Company, Division Of Conopco, Inc. Thickening system
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5460834A (en) * 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
WO1993017664A1 (en) 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
CA2134376C (en) * 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
ATE166227T1 (de) * 1994-03-18 1998-06-15 Senju Pharma Co Sarpogrelat enthaltende opthalmologische zubereitungen zur senkung des intraokularen druckes
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
ES2206965T3 (es) 1997-07-29 2004-05-16 Alcon Laboratories, Inc. Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
DE69826730T2 (de) * 1997-07-29 2005-02-10 Alcon Laboratories, Inc., Fort Worth Konditionierungslösungen für die Pflege von harten Kontaktlinsen
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
AR035509A1 (es) * 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
AU2002360752A1 (en) 2001-12-21 2003-07-30 Alcon, Inc. Viscoelastics for ocular surgery
AU2003213210A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic formulation with gum system
EP1624858B1 (en) * 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Novel encochleation methods
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
CN100475192C (zh) 2003-06-13 2009-04-08 爱尔康公司 包含两种聚合物的协同组合的眼用组合物
TWI336257B (en) 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers

Also Published As

Publication number Publication date
BRPI0411367B1 (pt) 2017-05-02
WO2004112750A2 (en) 2004-12-29
US20040253202A1 (en) 2004-12-16
ZA200509441B (en) 2007-03-28
JP2011026355A (ja) 2011-02-10
EP1633324B1 (en) 2006-12-20
MXPA05013293A (es) 2006-03-09
CY1105877T1 (el) 2011-02-02
JP4657213B2 (ja) 2011-03-23
CA2527417C (en) 2013-12-03
US7306802B2 (en) 2007-12-11
KR101082345B1 (ko) 2011-11-10
ATE348600T1 (de) 2007-01-15
US20070231294A1 (en) 2007-10-04
JP2006528990A (ja) 2006-12-28
WO2004112750A3 (en) 2005-08-18
EP1633324A2 (en) 2006-03-15
PT1633324E (pt) 2007-01-31
US7244440B2 (en) 2007-07-17
AU2004249136B2 (en) 2009-09-03
AU2004249136A1 (en) 2004-12-29
US20070224159A1 (en) 2007-09-27
CA2527417A1 (en) 2004-12-29
CN1802148A (zh) 2006-07-12
PL1633324T3 (pl) 2007-03-30
US7618620B2 (en) 2009-11-17
DK1633324T3 (da) 2007-04-02
ES2274476T3 (es) 2007-05-16
US20080075687A1 (en) 2008-03-27
TWI336257B (en) 2011-01-21
KR20060012023A (ko) 2006-02-06
DE602004003812T2 (de) 2007-04-26
JP5161950B2 (ja) 2013-03-13
DE602004003812D1 (de) 2007-02-01
US7329411B2 (en) 2008-02-12
AR047205A1 (es) 2006-01-11
CN100340233C (zh) 2007-10-03
BRPI0411367A (pt) 2006-07-25

Similar Documents

Publication Publication Date Title
MXPA05013290A (es) Composiciones oftalmicas que contienen una combinacion sinergistica de dos polimeros.
TW200501969A (en) Ophthalmic compositions containing a synergistic combination of three polymers
MX2009007774A (es) Composiciones oftalmicas que contienen una combinacion sinergistica de tres polimeros.
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2005001077A3 (en) Repair and regeneration of ocular tissue using postpartum-derived cells
TW200626132A (en) Topical nepafenac formulations
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
PT1521573E (pt) Composições de implantes farmacêuticos lipofílicos não poliméricos para utilização intra-ocular
WO2006052451A3 (en) Implantable collagen compositions
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
AU2003297684A1 (en) Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
AU2003272654A1 (en) Polymer compositions containing bioactive agents and methods for their use
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
WO2004041158A3 (en) Rifalazil compositions and therapeutic regimens
WO2006044155A3 (en) Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same
BRPI0417950A (pt) composições farmacêuticas
TW200631589A (en) Varnish composition based on a solvent of plant origin
WO2006128120A3 (en) Novel lapachone compounds and methods of use thereof
EP1683528A4 (en) POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
PL380665A1 (pl) Farmaceutyczne kompozycje
WO2004078180A3 (en) Naaladase inhibitors for treating opioid tolerance
AU2003256882A1 (en) Methods of drug delivery using sulphated chitinous polymers
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
EP1809599B8 (en) Vitamin d3 analogues for the prevention and treatment of bone disorders

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees